GT Biopharma (GTBP) Stock: Buy, Sell, or Hold?
$3.72
-0.12 (-3.12%)
▼
5d:
-15.84%
30d:
-49.46%
90d:
+1205.26%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
53/100
Position
OVERSOLD
30-Day Fair Range
$4.53 – $6.59
Position: OVERSOLD
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$75.00
+1916.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.60 / $5.40
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: GTBP is down 15.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When GTBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GTBP is currently trading at $3.72, which is considered oversold relative to its 30-day fair value range of $4.53 to $6.59.
Technical Outlook: Technically, GTBP is in a strong uptrend. Immediate support is located at $3.60, while resistance sits at $5.40. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $75.00 (+1916.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GTBP is in a strong uptrend. Immediate support is located at $3.60, while resistance sits at $5.40. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $75.00 (+1916.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.53 -
$6.59
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$4.53 -
$6.59
Current vs Trading Range
OVERSOLD
Support Level
$3.60
Resistance Level
$5.40
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 1916.1% below Wall St target ($75.00)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$75.00
(+1916.1%)
Share GTBP Analysis
Share this live GTBP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GTBP)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Jun 25, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding potential collaboration between $GTBP and $IBRX on nanobodies
Key Retail Themes:
Collaboration between $GTBP and $IBRX
Nanobodies
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:55 PM ET
Data refreshes hourly during market hours. Next update: 6:55 PM
Data refreshes hourly during market hours. Next update: 6:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GTBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 60 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 40 SELL |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 36 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 39 SELL |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GTBP Research Pages
